Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

DLBCL

  • <sup>18</sup>F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
    Open Access
    18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
    Kibrom B. Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont and Irène Buvat
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1925-1932; DOI: https://doi.org/10.2967/jnumed.121.263501
  • <sup>18</sup>F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study
    You have access
    18F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study
    Coreline N. Burggraaff, Jakoba J. Eertink, Pieternella J. Lugtenburg, Otto S. Hoekstra, Anne I.J. Arens, Bart de Keizer, Martijn W. Heymans, Bronno van der Holt, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Henrica C.W. de Vet, Josée M. Zijlstra and on behalf of the HOVON Imaging Working Group and the HOVON Lymphoma Working Group
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1001-1007; DOI: https://doi.org/10.2967/jnumed.121.262205
  • You have access
    Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment 18F-FDG PET in Diffuse Large B-Cell Lymphoma
    Tamás Györke, Robert Carr, Juliano J. Cerci, Claudio Meneghetti, Francisca Redondo, Monica Celli, Charity Gorospe, Chirayu U. Auewarakul, Linda Jorgov, Diana Paez and Stefano Fanti
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 999-1005; DOI: https://doi.org/10.2967/jnumed.119.231621
  • You have access
    18F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome
    Anne-Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, Jérôme Clerc, Franck Morschhauser, Olivier Casasnovas, Michel Meignan and Irène Buvat
    Journal of Nuclear Medicine January 1, 2020, 61 (1) 40-45; DOI: https://doi.org/10.2967/jnumed.119.229450
  • You have access
    Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma
    Constantin Lapa, Heribert Hänscheid, Malte Kircher, Andreas Schirbel, Gerd Wunderlich, Rudolf A. Werner, Samuel Samnick, Jörg Kotzerke, Hermann Einsele, Andreas K. Buck, Hans-Jürgen Wester and Götz Ulrich Grigoleit
    Journal of Nuclear Medicine January 1, 2019, 60 (1) 60-64; DOI: https://doi.org/10.2967/jnumed.118.210997
  • You have access
    Interobserver Agreement of Interim and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials
    Coreline N. Burggraaff, Alexander C. Cornelisse, Otto S. Hoekstra, Pieternella J. Lugtenburg, Bart De Keizer, Anne I.J. Arens, Filiz Celik, Julia E. Huijbregts, Henrica C.W. De Vet and Josée M. Zijlstra; on behalf of the HOVON Imaging Working Group
    Journal of Nuclear Medicine December 1, 2018, 59 (12) 1831-1836; DOI: https://doi.org/10.2967/jnumed.118.210807
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire